Skip to main content
mosquito

Dengue Vax/Zika Challenge (CIR 369)

Outpatient Study enrolling healthy adults 18-40 years old

The purpose of this study is to test the effects of the ZIKA virus against a Dengue vaccine. We hope to see if the Dengue vaccine is effective to protect individuals against the Zika virus. 

The study is:

  • 1 year long
  • enrolling healthy adults 18-40 years old
  • at least 2 screening visits
  • 1 vaccination visit
  • 12 follow up visits after vaccination
  • 1 zika challenge visit
  • 19 follow up visits after challenge

Screening Dates

September 4, 2024

September 9, 2024

September 16, 2024

September 18, 2024

Screening Location(s)

CIR Johns Hopkins East Baltimore Campus

Rangos Building

855 N. Wolfe Street Suite 601

Baltimore, MD 21205

Study Period

One year

Compensation

Up to $6100